BGLAX | VCRCX | BGLAX / VCRCX | |
Total Expense Ratio | 1.25 | 2.08 | 60% |
Annual Report Gross Expense Ratio | 1.43 | 2.10 | 68% |
Fund Existence | 13 years | 6 years | - |
Gain YTD | 4.766 | 6.443 | 74% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 200M | 882M | 23% |
Annual Yield % from dividends | 1.51 | 0.77 | 195% |
Returns for 1 year | 16.10 | 14.69 | 110% |
Returns for 3 years | -1.12 | 4.32 | -26% |
Returns for 5 years | 51.96 | 55.98 | 93% |
Returns for 10 years | 30.53 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIS | 19.65 | 0.70 | +3.69% |
ProShares UltraShort Nasdaq Biotech | |||
SPBO | 29.04 | 0.01 | +0.03% |
SPDR® Portfolio Corporate Bond ETF | |||
PTBD | 20.12 | -0.01 | -0.05% |
Pacer Trendpilot US Bond ETF | |||
FLSW | 35.42 | -0.10 | -0.28% |
Franklin FTSE Switzerland ETF | |||
PSFF | 28.01 | -0.70 | -2.44% |
Pacer Swan SOS Fund of Funds ETF |